$0.778
+0.029 (+3.69%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CTOR por análisis de gráficos similares
Alphio's CTOR stock price prediction model matches the current Citius Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.75 (-3.56%). The 1-week path is $0.74 (-4.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Citius Oncology Inc?
Citius Oncology Inc (CTOR) presents a compelling buy opportunity right now, primarily driven by its recent positive developments in drug commercialization and strong analyst support. The stock is currently priced at $0.78, with a forward P/E ratio of 35.59, indicating potential growth despite current losses. The gross margin for Q1 2026 stands at an impressive 79.99%, suggesting efficient cost management in its operations. However, the main risk lies in the company's significant net loss of $26.61 million reported in Q2 2026, which could impact its financial stability moving forward.
CTOR cerró en $0.78 el Wednesday, tras subir +3.69%
Citius Oncology Inc (CTOR) last closed at $0.7777, gaining +3.69%. These facts feed the 1-day and 1-week CTOR price prediction above.
Factores de la previsión
Los factores de la previsión de Citius Oncology Inc (CTOR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CTOR, ordenadas por similitud.
Análisis de estacionalidad de CTOR
Historically the probability of a positive September return for CTOR is 47.73%. February offers the highest probability of a positive month at 81.03%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.